2012
DOI: 10.1016/j.exppara.2011.12.014
|View full text |Cite
|
Sign up to set email alerts
|

Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1,3,5-triazine derivatives: A novel and potential antifolate lead for Pf-DHFR-TS inhibition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
30
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
10

Relationship

4
6

Authors

Journals

citations
Cited by 68 publications
(30 citation statements)
references
References 18 publications
0
30
0
Order By: Relevance
“…Some are also used for the treatment of HIV infection [4][5][6]. Several workers have investigated s-triazine derivatives in the scope of potential therapeutic agents for diseases due to bacteria [7][8][9][10], cancer [11][12][13], antitumor [14,15], and malaria [16,17]. This literature survey led us to consider the s-triazine system as a possible scaffold.…”
Section: Introductionmentioning
confidence: 98%
“…Some are also used for the treatment of HIV infection [4][5][6]. Several workers have investigated s-triazine derivatives in the scope of potential therapeutic agents for diseases due to bacteria [7][8][9][10], cancer [11][12][13], antitumor [14,15], and malaria [16,17]. This literature survey led us to consider the s-triazine system as a possible scaffold.…”
Section: Introductionmentioning
confidence: 98%
“…Multiple computational approaches like ab initio molecular orbital and density functional theory calculations, along with the molecular electrostatic potential analysis, and molecular docking were also utilized by our research group for the design of 1H-imidazole-2,4-diamine derivatives as potential inhibitors of PfDHFR enzyme (Adane & Bharatam, 2011). Many scientific groups have also identified many novel classes of PfDHFR inhibitors such as 2,4-diaminopyrimidines (Falco, Goodwin, Hitchings, Rollo, & Russell, 1951), 2-amino-1,4-dihydro-4,4,7,8-tetramethyl-s-triazino(1,2-a)benzimida zole and Trp-P-2 series (Toyoda et al, 1997), 5-Benzyl-2,4-diamonopyrimidines (Sirichaiwat et al, 2004), novel biguanide analogs (RJF001302, RJF00670 and RJF00719) (Dasgupta et al, 2009), 2-methyl-6-ureido-4-quinolinamides (Madapa et al, 2009, 4-anilinoquinoline triazines , 1,2,3-Triazole tethered β-lactam and 7-chloroquinoline bifunctional hybrids , hybrid phenylthiazolyl-1,3,5-triazine derivatives (Gahtori et al, 2012), 4-aminoquinoline and 1,3,5-triazine derivatives Bhat et al, 2013), and 2-Aminopyrimidinebased 4-aminoquinoline antiplasmodial agents (Singh, Kaur et al, 2012). More recently, our research group has implemented computer-aided methods for the design of new class of S-benzylated guanylthiourea compounds (Figure 1), which were synthesized later and tested for their biological activity.…”
Section: Introductionmentioning
confidence: 99%
“…It is used to predict the preferred orientation, affinity and activity of ligands (small molecules) into the active site of target protein through a process involving series of steps. In continuation of our research endeavour on discovery of novel anti-infective agents from 1,3,5-triazines (Gahtori et al 2009; Singh et al 2011; Bhat et al 2011; Gahtori et al 2012a; Gahtori et al 2012b; Gahtori and Ghosh et al 2012; Ghosh et al 2012; Bhat et al 2012, Singh et al 2012). We have tried to work out the inhibitory effect of hybrid phenylthiazole-1,3,5-triazines on the candida albicans cytosolic leucyl-tRNA synthetase editing domain through molecular docking studies to elucidate probable mechanism of action of 1,3,5-triazine as antifungal agent.…”
Section: Introductionmentioning
confidence: 99%